Your browser doesn't support javascript.
loading
Emerging therapies and respiratory infections: Focus on the impact of immunosuppressants and immunotherapies.
Patterson, Caroline M; Shaw, Timothy D; Gerovasili, Vicky; Khatana, Usman; Jose, Ricardo J.
Afiliação
  • Patterson CM; Consultant in Respiratory Transplant Medicine, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK. Electronic address: caroline.patterson@nhs.net.
  • Shaw TD; Academic Clinical Lecturer in Infectious Diseases and Medical Microbiology, Wellcome-Wolfson Institute for Experimental Medicine, Queen's University, Belfast, UK.
  • Gerovasili V; Consultant in Respiratory Transplant Medicine, Royal Brompton and Harefield hospital, part of Guys and St Thomas NHS Foundation trust, London, UK.
  • Khatana U; Specialty Trainee in Respiratory Medicine, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK.
  • Jose RJ; Consultant in Host Defence, Royal Brompton and Harefield hospital, part of Guys and St Thomas NHS Foundation trust, London, UK.
Clin Med (Lond) ; 24(1): 100015, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38387208
ABSTRACT
Host defences to infection are based upon an integrated system of physical and biochemical barriers, innate and adaptive immunity. Weakness in any of these defensive elements leads to increased susceptibility to specific pathogens. Understanding how medical therapies disrupt host defences is key to the successful prevention, diagnosis and management of respiratory infection in the immunocompromised host.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Respiratórias / Imunossupressores Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Respiratórias / Imunossupressores Idioma: En Ano de publicação: 2024 Tipo de documento: Article